Folgen
Bailiang Li
Bailiang Li
Personalis, Inc.
Bestätigte E-Mail-Adresse bei personalis.com
Titel
Zitiert von
Zitiert von
Jahr
Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non–small cell lung cancer
B Li, Y Cui, M Diehn, R Li
JAMA oncology 3 (11), 1529-1537, 2017
3292017
The Immune Subtypes and Landscape of Squamous Cell CarcinomaImmune Landscape of Squamous Cell Carcinoma
B Li, Y Cui, DK Nambiar, JB Sunwoo, R Li
Clinical Cancer Research 25 (12), 3528-3537, 2019
962019
Heterogeneous enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with dysregulated signaling pathways and poor survival in breast cancer
J Wu, B Li, X Sun, G Cao, DL Rubin, S Napel, DM Ikeda, AW Kurian, R Li
Radiology 285 (2), 401, 2017
742017
Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular PathwaysImaging Subtypes of Breast Cancer
J Wu, Y Cui, X Sun, G Cao, B Li, DM Ikeda, AW Kurian, R Li
Clinical Cancer Research 23 (13), 3334-3342, 2017
712017
Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway
H Liu, ZQ Yan, B Li, SY Yin, Q Sun, JJ Kou, D Ye, K Ferns, HY Liu, SL Liu
Journal of ovarian research 7 (1), 1-9, 2014
532014
Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast CancerPredictive Biomarker for Breast Radiotherapy
Y Cui, B Li, EL Pollom, KC Horst, R Li
Clinical Cancer Research 24 (19), 4754-4762, 2018
402018
Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit
B Li, Y Jiang, G Li, GA Fisher Jr, R Li
JCI insight 5 (9), 2020
362020
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease
MJ Mason, C Schinke, CLP Eng, F Towfic, F Gruber, A Dervan, BS White, ...
Leukemia 34 (7), 1866-1874, 2020
282020
A quantitative CT imaging signature predicts survival and complements established prognosticators in stage I non-small cell lung cancer
J Lee, B Li, Y Cui, X Sun, J Wu, H Zhu, J Yu, MF Gensheimer, BW Loo Jr, ...
International Journal of Radiation Oncology* Biology* Physics 102 (4), 1098-1106, 2018
222018
A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation
X Zhou, B Li, Y Zhang, Y Gu, B Chen, T Shi, L Ao, P Li, S Li, C Liu, Z Guo
Breast cancer research and treatment 142 (3), 505-514, 2013
172013
Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC
J Lee, Y Cui, X Sun, B Li, J Wu, D Li, MF Gensheimer, BW Loo, M Diehn, ...
European radiology 28 (2), 736-746, 2018
152018
Single-cell spatial analysis of tumor and immune microenvironment on whole-slide image reveals hepatocellular carcinoma subtypes
H Wang, Y Jiang, B Li, Y Cui, D Li, R Li
Cancers 12 (12), 3562, 2020
122020
Complete genome sequence of Salmonella enterica subspecies arizonae str. RKS2983
CX Wang, SL Zhu, XY Wang, Y Feng, B Li, YG Li, RN Johnston, GR Liu, ...
Standards in Genomic Sciences 10 (1), 1-7, 2015
102015
Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatment
B Li, Y Li, XY Wang, ZQ Yan, H Liu, GR Liu, SL Liu
American Journal of Cancer Research 5 (2), 726, 2015
102015
Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer
C Jin, Y Jiang, H Yu, W Wang, B Li, C Chen, Q Yuan, Y Hu, Y Xu, Z Zhou, ...
British Journal of Surgery 108 (5), 542-549, 2021
92021
Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers
X Zhou, T Shi, B Li, Y Zhang, X Shen, H Li, G Hong, C Liu, Z Guo
PLoS One 8 (7), e70017, 2013
82013
Deconvolution of the gene expression profiles of valuable banked blood specimens for studying the prognostic values of altered peripheral immune cell proportions in cancer patients
L Qi, B Li, Y Dong, H Xu, L Chen, H Wang, P Li, W Zhao, Y Gu, C Wang, ...
PLoS One 9 (6), e100934, 2014
72014
Alternative splicing-based differences between hepatocellular carcinoma and intrahepatic cholangiocarcinoma: genes, immune microenvironment, and survival prognosis
D Luo, D Zhao, M Zhang, C Hu, H Li, S Zhang, X Chen, L Huttad, B Li, ...
Frontiers in oncology 11, 2021
42021
B cell-related gene signature and cancer immunotherapy response
A Lundberg, B Li, R Li
British Journal of Cancer 126 (6), 899-906, 2022
12022
Predicting High-Risk Individuals for Common Diseases Using Multi-Omics and Epidemiological Data
D Chowdhury, X Zhou, B Li, Y Zhang, WK Cheung, A Lu, L Zhang
Frontiers in Genetics 12, 2021
12021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20